Kornitzer Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $757K | Buy |
1,700
+1,032
| +154% | +$459K | 0.02% | 421 |
|
|
2025
Q1 | $324K | Buy |
668
+3
| +0.5% | +$1.45K | 0.01% | 443 |
|
|
2024
Q4 | $268K | Sell |
665
-1,308
| -66% | -$527K | 0.01% | 457 |
|
|
2024
Q3 | $918K | Sell |
1,973
-1
| -0.1% | -$465 | 0.02% | 396 |
|
|
2024
Q2 | $925K | Buy |
1,974
+237
| +14% | +$111K | 0.02% | 397 |
|
|
2024
Q1 | $726K | Hold |
1,737
| – | – | 0.01% | 420 |
|
|
2023
Q4 | $707K | Sell |
1,737
-550
| -24% | -$224K | 0.01% | 411 |
|
|
2023
Q3 | $795K | Sell |
2,287
-1,275
| -36% | -$443K | 0.02% | 413 |
|
|
2023
Q2 | $1.25M | Hold |
3,562
| – | – | 0.02% | 379 |
|
|
2023
Q1 | $1.12M | Hold |
3,562
| – | – | 0.02% | 386 |
|
|
2022
Q4 | $1.03M | Hold |
3,562
| – | – | 0.02% | 393 |
|
|
2022
Q3 | $1.03M | Hold |
3,562
| – | – | 0.02% | 400 |
|
|
2022
Q2 | $1M | Buy |
3,562
+900
| +34% | +$254K | 0.02% | 406 |
|
|
2022
Q1 | $695K | Buy |
+2,662
| New | +$695K | 0.01% | 455 |
|
|
2017
Q3 | – | Sell |
-156,835
| Closed | -$20.2M | – | 475 |
|
|
2017
Q2 | $20.2M | Sell |
156,835
-265
| -0.2% | -$34.2K | 0.35% | 92 |
|
|
2017
Q1 | $17.2M | Buy |
+157,100
| New | +$17.2M | 0.31% | 106 |
|